Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

NCT00001381 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00001381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
March 31, 1994
Completion date
December 31, 2000
Enrollment
18
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder neoplasms, carcinoma, transitional cell